Utilizing cohort-level and individual networks to predict best response in patients with metastatic triple negative breast cancer
Open Access
- 13 June 2025
- journal article
- research article
- Published by Springer Nature in npj Precision Oncology
- Vol. 9 (1) , 1-13
Abstract
Given the highly aggressive and heterogeneous nature of metastatic triple-negative breast cancer, molecular subtypes have been evaluated for their utility in patient stratification and therapeutic selection. Leveraging both our unique longitudinal multimodal analysis of serial tumor biopsies, as well as existing public reference cohorts, we refined clinically relevant molecular subtypes through de-novo network-based approaches. A plasma/B-cell related co-expression module emerged as a robust predictor of clinical response. Refinements of this module were significantly associated with pathological complete response and survival in the CALGB and METABRIC cohorts, as well as dramatically improving the call rate in a CLIA setting. We explored patient-specific networks to monitor individual adaptive responses to therapy, allowing for dynamic adjustments in treatment strategies. Our work supports the shift from traditional molecular subtyping towards a more integrated view that includes the tumor microenvironment and immune landscape in a network-based context.Keywords
This publication has 56 references indexed in Scilit:
- Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancerCancer Cell, 2021
- Estimating Sample-Specific Regulatory NetworksiScience, 2019
- Near-optimal probabilistic RNA-seq quantificationNature Biotechnology, 2016
- The Molecular Signatures Database Hallmark Gene Set CollectionCell Systems, 2015
- Biological subtypes of triple-negative breast cancer are associated with distinct morphological changes and clinical behaviourThe Breast, 2013
- TCPA: a resource for cancer functional proteomics dataNature Methods, 2013
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroupsNature, 2012
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1Nature, 2009
- Weighted gene coexpression network analysis strategies applied to mouse weightMammalian Genome, 2007